Viewing Study NCT03812393


Ignite Creation Date: 2025-12-25 @ 1:18 AM
Ignite Modification Date: 2026-02-18 @ 5:29 AM
Study NCT ID: NCT03812393
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2023-12-18
First Post: 2019-01-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluating the Efficacy of Neratinib on Live Cell HER2 Signaling Transduction Analysis Positive Triple Negative Breast
Sponsor: West Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Triple Negative Breast Cancer View
None Early-stage Breast Cancer View
None HER2-positive Breast Cancer View
Keywords: